What's New on the FDA Drugs Site
May 19, 2016
- Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment Guidance for Industry (PDF - 388 KB)
- Comunicado de la FDA sobre la seguridad de los medicamentos: La FDA aconseja restringir el uso de antibióticos a base de fluoroquinolonas para ciertas infecciones sin complicaciones; advierte sobre efectos secundarios discapacitantes que pueden presentarse juntos
- Drug Approval Package: Venclexta Tablets
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- FDA Drug Safety Communication: FDA warns that prescribing of Nizoral (ketoconazole) oral tablets for unapproved uses including skin and nail infections continues; linked to patient death
- Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies (updated)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario